Trademark: 85547257
Word
ZIPSTA
Status
Dead
Status Code
606
Status Date
Monday, February 8, 2016
Serial Number
85547257
Mark Type
4000
Filing Date
Monday, February 20, 2012
Published for Opposition
Tuesday, November 6, 2012
Abandoned Date
Monday, February 8, 2016

Trademark Owner History
Eli Lilly and Company - Owner At Publication

Classifications
5 Veterinary preparations for destroying vermin, namely, insecticides for use with livestock and livestock premises; antibiotics for use in livestock; veterinary preparations for the treatment of enteric clostridium infections; veterinary preparations for the prevention of enteric clostridium infections; veterinary preparations in the treatment of Cushing's disease in animals; veterinary preparations for the control and symptomatic relief of viral and bacterial infectious diseases of cattle; immunorestorative biopharmaceutical for enhancing the immune system of cattle; veterinary preparations for controlling and destroying vermin, namely, insecticides and pesticides for use with poultry and livestock animals and poultry and livestock premises; veterinary preparations, namely, vaccines, antimicrobials and other medicinal drugs for the prevention, treatment, control, or symptomatic relief of infectious, non-infectious and metabolic diseases of poultry and livestock; animal feed supplements; medicated feed and water additives for animals; veterinary preparations for food safety, namely, anti-microbial preparations for inhibiting microbiological decomposition in food and animal feed; veterinary preparations, namely, anti-microbials and vaccines for food safety and food animal processing; antibacterial pharmaceuticals; veterinary preparations for production improvement for poultry and livestock, namely, medicated feed additives for poultry and livestock and medicated water additives for poultry and livestock; diagnostic agents, tests, preparations and substances to identify pathogens or residues of biological interest for veterinary use; bactericides, namely, bacteriophage used as a human food safety agent to reduce levels of food borne pathogens carried on livestock or meat prior to being processed for human consumption; bacterial vector based vaccines relating to infection and non-infectious diseases or productivity loss in all avian, ruminant and swine species, the prevention or reduction of contamination of food produced by any or all avian, ruminant or swine species, the prevention of food-borne diseases in humans associated with contact with or consumption of food produced by any or all avian, ruminant or swine species; pathogen reduction preparations for pathogens that are in or on animals and that take the form of bacteria contaminants in meat which may be found in the livestock's digestive systems, or on the livestock during the harvest and processing phases; pathogen reduction treatment preparation for use on treating bacteria contaminants in meat which may be found in the livestock's digestive systems, or on the livestock during the harvest and processing phases; veterinary preparations containing natural plant extracts for oral administration to avian species and other livestock as an aid in managing health risks and productivity, namely, veterinary preparations for infection and non-infectious diseases or productivity loss in avian species and other livestock; Veterinary preparations for use in the treatment of fleas on pets; veterinary preparations for use in the prevention of fleas on pets; insecticides to prevent fleas on pets; transdermal drug delivery products for use on companion and food animals, namely, skin penetration medicine for pain and inflammation; veterinary preparations for companion animals in the treatment of parasitic infestations; transdermal topical solution administered by veterinarians in a surgical setting to treat pain in companion animals; veterinary preparations for companion animals in the treatment of anxiety, diabetes, hyperthyroidism, hypothyroidism, obesity, urine spraying, urinary incontinence; dental and oral disease, namely, stomatitis, Feline Odontoclastic Resorptive Lesion, periodontitis; veterinary preparations for companion animals in the treatment of chronic pain associated with osteoarthritis and cancer; veterinary preparations for companion animals in the treatment of gastrointestinal disorders associated with cholangiohepatitis, inflammatory bowel disorder, pancreatitis, gastritis, chronic colitis, enteritis; veterinary preparations for companion animals in the treatment of central nervous systems diseases and disorders, namely, cerebellar hypoplasia, cerebellar abiotrophy, laryngeal paralysis, meningoencephalitis, syringomyelia; veterinary preparations for companion animals in the treatment of neurological and neurodegenerative disorders, namely, seizure, epilepsy, neuropathies; veterinary preparations for companion animals in the treatment of parasitic infections and infestations associated with acaricides, heartworm, GI nematodes, mange, fleas; veterinary preparations for companion animals in the treatment of cardiovascular conditions namely, hypertension, cardiomyopathies, hear murmurs, heart failure; veterinary preparations for companion animals in the treatment of dermatologic conditions, namely, canine atopic dermatitis, skin rash, flea allergy, food allergy, cancer; veterinary preparations for companion animals in the treatment of chronic kidney disease and associated conditions namely, anemia, hyperphosphatemia, hypocalcemia, hypertension, cachexia; veterinary preparations for companion animals in the treatment of acute pain associated with orthopedic and soft tissue surgery, trauma, and musculoskeletal conditions; veterinary preparations for companion animals in the treatment of osteoarthritis, otitis and wound healing; veterinary preparations for companion animals in the treatment of infections, namely, upper respiratory; veterinary preparations for companion animals in the treatment of allergy atopic conditions associated with atopic dermatitis, seasonal allergies, asthma; veterinary preparations for companion animals in the treatment of liver disease, acute and chronic hepatitis; nonsurgical sterilization

Trademark Events
Feb 8, 2016
Abandonment Notice Mailed - No Use Statement Filed
Feb 8, 2016
Abandonment - No Use Statement Filed
Jul 10, 2015
Notice Of Approval Of Extension Request E-Mailed
Jul 9, 2015
Extension 5 Granted
Jun 26, 2015
Extension 5 Filed
Jun 26, 2015
Teas Extension Received
Dec 17, 2014
Notice Of Approval Of Extension Request E-Mailed
Dec 16, 2014
Extension 4 Granted
Dec 12, 2014
Extension 4 Filed
Dec 12, 2014
Teas Extension Received
Jun 17, 2014
Notice Of Approval Of Extension Request E-Mailed
Jun 16, 2014
Extension 3 Granted
Jun 10, 2014
Extension 3 Filed
Jun 10, 2014
Teas Extension Received
Feb 11, 2014
Notice Of Approval Of Extension Request E-Mailed
Feb 10, 2014
Extension 2 Granted
Dec 16, 2013
Extension 2 Filed
Jan 31, 2014
Case Assigned To Intent To Use Paralegal
Dec 16, 2013
Teas Extension Received
May 30, 2013
Notice Of Approval Of Extension Request E-Mailed
May 28, 2013
Extension 1 Granted
May 28, 2013
Extension 1 Filed
May 28, 2013
Teas Extension Received
Jan 1, 2013
Noa E-Mailed - Sou Required From Applicant
Nov 6, 2012
Official Gazette Publication Confirmation E-Mailed
Nov 6, 2012
Published For Opposition
Oct 17, 2012
Notification Of Notice Of Publication E-Mailed
Oct 1, 2012
Law Office Publication Review Completed
Sep 13, 2012
Assigned To Lie
Sep 4, 2012
Approved For Pub - Principal Register
Sep 1, 2012
Teas/Email Correspondence Entered
Aug 31, 2012
Correspondence Received In Law Office
Aug 31, 2012
Teas Response To Office Action Received
Mar 28, 2012
Notification Of Non-Final Action E-Mailed
Mar 28, 2012
Non-Final Action E-Mailed
Mar 28, 2012
Non-Final Action Written
Mar 23, 2012
Assigned To Examiner
Feb 27, 2012
New Application Office Supplied Data Entered In Tram
Feb 23, 2012
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24